iDtheinvestordatabase
Home / Directory / Great Oaks Venture Capital
Likely active: portfolio news Sep 2026 Verified 5 Nov 2026

Great Oaks Venture Capital

Seed-stage generalist investor writing early checks in pre-seed, seed and Series A rounds, with most activity in software, healthcare, financial services, marketplaces and enterprise. Based in New York, NY.

Type
VC firm
Location
New York, New York, United States
Stages
Pre-seed, Seed, Series A
Backs
B2B software, Medtech and digital health, Consumer products
Sectors
Healthtech and life sciences, Generalist, SaaS and software, Fintech, Marketplace, B2B
Fund size / AUM
$20M gross private fund assets (Form ADV; private funds: 3, of which venture capital: 3)
Portfolio mix
B2B software 37%; Medtech and digital health 22%; Consumer products 15%; Consumer apps 7%; Climate and energy 7%; Marketplaces 4%; Hardware 4%; Fintech 4% (n=27)

Contacts on file

For Great Oaks Venture Capital, the paid file holds: 6 named decision-makers with roles; check size; LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

1Life33AcrossAcornsAffinity

Sources

Last checked 5 Nov 2026. Is something wrong? Tell us.

Appears in 83 lists

Series A marketplace investors in the US (16)Pre-seed marketplace investors in the US (18)CPG investors in New York (19)Series A CPG investors in the US (27)Seed marketplace investors in the US (32)B2B investors in New York (34)Pre-seed CPG investors in the US (35)Pre-seed marketplace investors (38)Series A CPG investors (41)Series A marketplace investors (42)Pre-seed CPG investors (43)Marketplace venture capital firms in the US (45)Series A investors in New York (49)Medtech investors in New York (53)Consumer investors in New York (59)Seed marketplace investors (68)Seed CPG investors in the US (73)Series A medtech investors in the US (76)Series A B2B investors in the US (79)Series A consumer investors in the US (80)Pre-seed investors in New York (82)Pre-seed B2B investors in the US (86)Pre-seed medtech investors in the US (95)Marketplace investors (97)Fintech investors in New York (98)Seed CPG investors (99)Healthtech investors in New York (100)Pre-seed consumer investors in the US (104)Series A medtech investors (125)Seed investors in New York (128)Pre-seed medtech investors (129)CPG venture capital firms in the US (130)SaaS investors in New York (138)Series A fintech investors in the US (145)Series A consumer investors (154)Pre-seed B2B investors (155)Series A B2B investors (157)Pre-seed consumer investors (162)Series A healthtech investors in the US (164)CPG investors (165)Seed B2B investors in the US (183)Pre-seed fintech investors in the US (187)Seed medtech investors in the US (205)Seed consumer investors in the US (216)Pre-seed healthtech investors in the US (225)Series A SaaS investors in the US (256)B2B venture capital firms in the US (257)Seed medtech investors (278)Series A fintech investors (294)Seed B2B investors (302)Pre-seed fintech investors (323)Seed consumer investors (331)Consumer venture capital firms in the US (348)Seed fintech investors in the US (349)Medtech venture capital firms in the US (350)Pre-seed SaaS investors in the US (367)Series A investors in the US (372)Series A healthtech investors (401)Pre-seed healthtech investors (408)Seed healthtech investors in the US (437)B2B investors (438)Venture capital firms in New York (440)Medtech investors (457)Series A SaaS investors (475)Consumer investors (512)Fintech venture capital firms in the US (525)Generalist investors (526)Pre-seed investors in the US (549)Pre-seed SaaS investors (562)Seed fintech investors (584)Seed SaaS investors in the US (666)Healthtech venture capital firms in the US (709)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Pre-seed investors (988)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Healthtech investors (1,207)SaaS investors (1,529)Seed investors (1,892)Venture capital firms in the US (2,975)